Project Selective DNA Repair Inhibitors for Cancer Therapy Program Pharmacy Term Academic Year 2023 Status Accepted Research Area Medicinal Chemistry Description The objective of this project is to develop a new class of highly selective pharmaceutical agents that inhibit DNA repair in cancers. Supervisor Vincent Jo Davisson Mentor Type of work required The student will be conduct in silico and biochemical studies of novel protein-protein interaction inhibitors targeting DNA repair in tumor models. Websites Qualifications GPA > 2.95; standing in the curriculum consistent with on-time graduation; biochemical or pharmaceutical sciences background Credit Hours 3 Weekly Hours 12 (estimated)